Novo CEO pressed by Senate to cut prices of obesity, diabetic issues medications CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would take into consideration new talks with insurers about the record costs of Wegovy and copyright if they pledge to keep the medicines on their formularies. This strategy aligns https://busch-light-peach-nutriti62716.blogdemls.com/30442741/5-simple-techniques-for-healthcare-news